-The Indian Express MHA’s decision to replicate the Chhattisgarh model in all Maoist-affected states is timely Taking a cue from the Chhattisgarh police’s efforts to socially rehabilitate Maoists cadres who have surrendered, the ministry of home affairs (MHA) has issued an advisory saying that all Naxal-affected states should facilitate reverse vasectomy operations for Maoists who wish to join the mainstream. The states should bear the medical costs for the operation, which will...

-The Hindu Drugs Controller must be told of adverse events within 24 hours Under sharp criticism for inadequate monitoring of clinical trials in the country, the Union Government is contemplating major changes in the Drugs & Cosmetics Act, 1940, and its Rules. These would make it mandatory for the Investigator to report all serious adverse events, including deaths, to the Drugs Controller General of India (DGCI), as well as the sponsor and...

-Live Mint The prime source of financing will be from general taxation or public exchequer, says Planning Commission Government-run hospitals may stop charging for primary services such as investigative tests as India attempts to provide universal health coverage to all its citizens. “No fee of any kind would be levied on primary healthcare services with the prime source of financing being from general taxation/public exchequer,” the Planning Commission says in its latest health...

-The Economic Times KOLKATA: The holy Ganga is a poison river today. It's so full of killer pollutants that those living along its banks in Uttar Pradesh, Bihar and Bengal are more prone to cancer than anywhere else in the country, says a recent study.  Conducted by the National Cancer Registry Programme (NCRP) under the Indian Council of Medical Research, the national study throws up shocking findings. The river is thick with...

-Live Mint The first in a two-part series examining the opaque world of clinical trials in India  A hospital in Indore has been able to get away with unethical medical trials in which 32 people have died over five years, according to the state government. This despite several investigations, a state government ban and Supreme Court strictures—a classic example of the lawless nature of the clinical trial business in India.   Lata Mehra, who...